How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/upper-respiratory-pneumococcal-infection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Upper Respiratory Pneumococcal Infection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Upper Respiratory Pneumococcal Infection (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Upper Respiratory Pneumococcal Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Penicillin G Potassium In Plastic Container	Benzylpenicillin	Pfizer	Penicillin-class Antibacterial		1947-01-01
penicillin	penicillin	Karlstad University		Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM
Phenoxymethylpenicillin	Phenoxymethylpenicillin	Katarina Hedin		Bacterial penicillin-binding protein, Penicillin-binding protein 1A

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Karlstad University · 1 drug in Upper Respiratory Pneumococcal Infection
Katarina Hedin · 1 drug in Upper Respiratory Pneumococcal Infection
Pfizer · 1 drug in Upper Respiratory Pneumococcal Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Upper Respiratory Pneumococcal Infection:

Cite this brief

Drug Landscape (2026). Upper Respiratory Pneumococcal Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/upper-respiratory-pneumococcal-infection. Accessed 2026-06-10.

Upper Respiratory Pneumococcal Infection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing